Benzodiazepine discontinuation difficulties in panic disorder: Conceptual model and outcome for cognitive-behavior therapy

M. W. Otto, J. J. Hong, S. A. Safren

Research output: Contribution to journalReview article

36 Scopus citations

Abstract

There is consistent support for the efficacy of cognitive-behavior therapy (CBT) to aid the successful discontinuation of benzodiazepine (BZ) medication in patients with panic disorder, and help these individuals maintain treatment gains while off medication. In this article, we provide a conceptual model for BZ discontinuation difficulties in patients with panic disorder. Outcome studies are reviewed, and are placed in the context of other evidence for the efficacy of CBT in patients with this disorder.

Original languageEnglish (US)
Pages (from-to)75-80
Number of pages6
JournalCurrent pharmaceutical design
Volume8
Issue number1
DOIs
StatePublished - May 8 2002
Externally publishedYes

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Fingerprint Dive into the research topics of 'Benzodiazepine discontinuation difficulties in panic disorder: Conceptual model and outcome for cognitive-behavior therapy'. Together they form a unique fingerprint.

  • Cite this